{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NuZycoIDA","lastupdate":"2022-10-27T00:00:00.000Z","update_date":"2022-10-27T00:00:00.000Z","lastModified":"Sep 15, 2025","active":1,"confidence_score":99,"confidence_score_reason":"funding rounds, markets","urlname":"eitan-medical","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$dgJKPK72JhbtYpexpt91BxaV1cYn0HmREQFRtQC06xD341k8BFD6lr.png","name":"Eitan Medical","oneliner":"Drug delivery & infusion pump solutions across the continuum of care- from the hospital to the home.","registrar":"514237122","website":"https://eitanmedical.com","careerspage":"","founded_month":1,"founded_year":2009,"formernames":["Sorrel Medical","Q Core Medical","Eitan Group","Avoset Health"],"sociallinks":{"twitter":"https://twitter.com/eitanmedical","youtube":"https://www.youtube.com/channel/UC66sUfVEqShu-cXd_J2KhAQ","facebook":"","linkedin":"https://www.linkedin.com/company/13020842","instagram":""},"social":["https://www.linkedin.com/company/13020842","https://www.youtube.com/channel/UC66sUfVEqShu-cXd_J2KhAQ","https://twitter.com/eitanmedical"],"flattenedsociallinks":"https://www.linkedin.com/company/13020842|https://www.youtube.com/channel/UC66sUfVEqShu-cXd_J2KhAQ|https://twitter.com/eitanmedical","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"201-500","employees_exact":289,"patent":1,"raised":0,"stage":"Mature","public_stage":"Mature","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Q Core Medical","Eitan Group","Avoset Health","Ethan Medical"],"about":"Eitan Medical is a medical device company that develops infusion therapy technologies for hospital care and ambulatory settings. Eitan Medical provides connected drug delivery and infusion solutions that are designed to improve patient and clinician quality of life across the continuum of care, including hospital, ambulatory, and home care environments. \nEitan Medical provides safe, intuitive, and flexible infusion solutions including the Sapphire™ platform of connected infusion systems in hospital & ambulatory settings; Avoset™ connected infusion system, focusing on the specialty infusion market, and digital health platform Eitan Insights™.\nEitan Medical has offices in the United States, France, and the United Kingdom as well as local service providers around the globe to support its customers, distributors, and partners.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+972732388888","country":null,"address":{"israeli":[{"id":"e299f1bf-2990-477e-9989-810f12644b39","city":"Netanya","type":null,"address":"Yad Harutsim Street 29, Netanya, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"4eba4de9-f866-4218-a718-06540c575e19","city":null,"address":"Didcot Enterprise Centre, Hawksworth, Didcot, UK","country":"United Kingdom","placeid":null},{"id":"794b3f1c-bd32-441f-8133-41bbd4b202ea","city":"Aliso Viejo","address":"65 Enterprise, Aliso Viejo, CA, USA","country":"United States","placeid":null},{"id":"e583d0d7-63b3-4ba9-98bd-1c4373ce72ae","city":"Marseille","address":"10 Place de la Joliette, Marseille, France","country":"France","placeid":null}]},"headquarter_address":null,"district":"Center District","news":[{"id":"EoF4rZUYO71RLdUsOJwh785gvN994i02KnMlHMu8HYegeKlJIhznTw","date":"Aug 1, 2022","link":"https://www.prnewswire.com/il/news-releases/eitan-medical-receives-iso-14001-environmental-management-certification-301596844.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"ISO certification, environmental impact","company":"Eitan Medical","layoffs":null,"summary":"Eitan Medical has earned ISO 14001 certification for its quality management system in the production of medical devices, demonstrating its commitment to reducing negative environmental impact. The certification reflects the companys dedication to creating a more sustainable healthcare ecosystem. Eitan Medical develops connected drug delivery and infusion solutions that improve patient and clinician quality of life. The companys product lines include the Sapphire infusion platform, the Sorrel wearable drug delivery platform, and the Avoset infusion pump. Eitan Medical is focused on delivering reliable innovations that prioritize patient safety and care. The certification aligns with the companys values and commitment to global sustainability standards.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["ISO certification","environmental impact","medical devices","drug delivery","sustainability"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"wI2SSD7AU3GwQHwRgIKX17J2fPgD3RUipAiSATHpG7yqCgnd0EQGxc","news_summary":"Eitan Medical Receives ISO 14001 Environmental Management Certification","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"w7MhyxUiVetMLh54juKWUTPX24WpGYqfNBVdKI13eRXHND3E8wadI5","date":"Nov 30, 2021","link":"https://www.prnewswire.com/il/news-releases/nhia-welcomes-eitan-medical-to-its-future-of-infusion-advisory-council-301434028.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"strategic partnership","company":"Eitan Medical","layoffs":null,"summary":"Eitan Medical has joined the National Home Infusion Associations Future of Infusion Advisory Council (FIAC) as part of a strategic partnership. The FIAC is a group of manufacturing and service companies focused on the home and alternate site infusion industry. Eitan Medicals addition to the council expands its international presence and will contribute to discussions on connected technology solutions for the industry. Eitan Medical develops drug delivery and infusion solutions for various healthcare settings. The partnership aims to improve the quality of infusion care for patients and enhance access to infusion solutions. The collaboration will help providers expand access to critical infusion services and monitor and improve patient care.","partners":"National Home Infusion Association (NHIA)","customers":null,"investors":null,"confidence":9,"key_topics":["NHIA","Future of Infusion Advisory Council","Eitan Medical","infusion industry","connected technology solutions"],"date_of_event":"2021-11-30","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Hqfw8yL7RwUawOqYdjZkLRAZsu7x0v5xpKwv3LJY5YZcpRyhhydERP","news_summary":"NHIA Welcomes Eitan Medical to its Future of Infusion Advisory Council","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4a62fa67-4550-4d8a-a586-017a6f699436","date":"Sep 26, 2021","link":"https://www.calcalist.co.il/market/article/hj00srtn7t","source":"www.calcalist.co.il","visible":1,"analysis":{"tags":"Acquisition, Public Trading, Expand","company":"Q Core (Eitan Medical)","layoffs":"N/A","summary":"Q Core, also known as Eitan Medical, is planning to merge with a SPAC (Special Purpose Acquisition Company) at a valuation of $1.3-1.4 billion. The company, which was acquired by Boaz Eitan 12 years ago, manufactures portable infusion systems. During the COVID-19 pandemic, Q Cores sales jumped to about $120 million per year. The company has also hired a foreign bank, likely Citibank, to facilitate the process. Q Cores main product is a portable infusion system that allows patients to receive infusions outside of the hospital. The companys products are sold in more than 25 countries.","partners":"Sevincli Yatırım Holding","customers":"Hospitals, nursing homes, clinics","investors":"Boaz Eitan, Tali Eitan","confidence":8,"key_topics":"Acquisition, NASDAQ, Infusion Systems, Medical Equipment, Growth","date_of_event":"N/A","valuation_amount":"$1.3-1.4 billion","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Acquisition, Public Trading, Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Acquisition, Public Trading, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"kO0czSxQochMUFOuLFmXAB2xRr3QVyfScOx3PSqal3bx9eig7h7fna","news_summary":"קיו קור של בועז איתן בדרך לנאסד\"ק  כלכליסט","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"nib7CzDoKG4UgAGQSp6iqye7ne6tpS9ynv8i0pmUFyoMvQidYn9oNw","date":"Sep 10, 2021","link":"https://www.prnewswire.com/news-releases/eitan-medical-announces-updated-distribution-arrangement-301372623.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"partnership","company":"Eitan Medical","layoffs":null,"summary":"Eitan Medical has announced that it will become the exclusive supplier and service provider for its own Sapphire Infusion System, taking over from ICU Medical. Eitan Medical will also distribute administration sets manufactured by ICU Medical for the Sapphire Infusion System. The transition marks the completion of a successful partnership between the two companies. Eitan Medical aims to enhance patient care and safety through innovation and exceptional customer experience. ICU Medical will now focus on its Best in KLAS Plum platform and ICU Medical MedNet software. Eitan Medical is a leader in drug delivery solutions, with the Sapphire infusion system being its flagship device.","partners":["ICU Medical"],"customers":["ICU Medical"],"investors":null,"confidence":9,"key_topics":["Eitan Medical","ICU Medical","Sapphire Infusion System","administration sets","patient-centricity"],"date_of_event":"September 10, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"rXkL7MYxQrMWkedu0SmC6tMBXBMk2UoKhkaXgZoE3h79ICOdRz36iY","news_summary":"Eitan Medical Announces Updated Distribution Arrangement","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"82813d7b-17d7-4011-9ea6-2d6b451286c8","date":"Mar 10, 2021","link":"https://www.jpost.com/health-science/israeli-medtech-start-up-receives-european-medical-device-regulation-approval-661516","source":"www.jpost.com","visible":1,"analysis":{"tags":"Regulatory Approval","company":"Eitan Medical","layoffs":"NA","summary":"Eitan Medical, an Israeli medtech company, has received EU Medical Device Regulation (MDR) 2017/45 certification for the newest upgrades to its Sapphire™ infusion pump accessories and administration sets. This comes two months after the company received FDA approval for its system software Rev15. The products are used by clinicians in hospitals and home care environments across Europe for pain management therapies. The company prioritized securing MDR clearance early this year to meet the most stringent up to date standards and enhance quality for its customers.","partners":"NA","customers":"Clinicians in hospitals and home care environments across Europe","investors":"NA","confidence":9,"key_topics":["EU MDR Certification","Infusion Pump Accessories","Pain Management Therapies","Quality Assurance","Patient Safety"],"date_of_event":"NA","valuation_amount":"NA","impact_on_company":"growth-positive","investment_amount":"NA","structured_issues":["Customers"],"acquisition_amount":"NA","structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"esLP2lmzYmV0InDLNdy5bgB26QngLzSMDRhmtqhEn25J1vVPAqiOBu","news_summary":"https://www.jpost.com/health-science/israeli-medtech-start-up-receives-european-medical-device-regulation-approval-661516","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"49e0f635-d546-4556-9f90-aa81a74611b3","date":"Jan 21, 2021","link":"https://www.prnewswire.com/il/news-releases/eitan-medical-receives-fda-clearance-for-upgraded-sapphire-infusion-pump-system-301210805.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"FDA clearance","company":"Eitan Medical","layoffs":null,"summary":"Eitan Medical has received FDA 510(k) clearance for its upgraded Sapphire infusion pump system software. The Sapphire infusion system is the companys flagship device used in various healthcare settings. The software upgrade includes key improvements such as adding the perineural route for pain management therapies, simplifying workflows, and enhancing maintenance functionality. Eitan Medical aims to provide innovative and reliable technologies that improve the user and patient experience. The clearance demonstrates the companys dedication to innovation and making their pumps easier to use for providers and safer for patients.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Sapphire infusion pump","FDA clearance","software upgrade","improved functionality","innovation"],"date_of_event":"January 19, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"WDxYtMBF2XERwYZLCPcrmbRvczHc4wLfE10nX10WivpXRQsqlypaJW","news_summary":"Eitan Medical Receives FDA Clearance for Upgraded Sapphire™ Infusion Pump System","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"fc20844c-4411-4b64-a5a4-e24f0adc80dd","date":"Sep 30, 2020","link":"https://www.globes.co.il/news/article.aspx?_atscid=7_134353_204082920_1579123_0_Txtetaxjxdshwhus8sp&did=1001344126","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Partnership, Expansion","company":"Sorel Medical","layoffs":"N/A","summary":"Sorel Medical, part of the Eitan Group, has signed a strategic partnership agreement with a leading global pharmaceutical company. Sorel develops wearable infusion pumps for the continuous delivery of drugs into the body. Under the partnership, the companies will integrate their drugs into Sorels devices. The most advanced of these combined products may reach the market by the end of 2021, following clinical trials. Following the signing of the partnership agreement, which is expected to generate revenue even before market entry, the company will expand its clean room factory in Netanya and recruit additional employees.","partners":"A leading global pharmaceutical company","customers":"N/A","investors":"N/A","confidence":8,"key_topics":["Strategic Partnership","Pharmaceutical Companies","Drug Delivery","Biological Drugs","Home Treatment"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Partners, Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Partners, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"4jw33GUDjoaAjYes9Yg4FNufHOEzN8BmWvlrUSgZEcXoZrvezYluWu","news_summary":"סורל מדיקל חתמה על הסכם שת\"פ אסטרטגי עם חברת פארמה גדולה","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ce53ab03-6ae8-4201-b099-d603a40f17d8","date":"Sep 18, 2020","link":"https://ondrugdelivery.com/andrei-yosef-ceo-sorrel-medical/","source":"ondrugdelivery.com","visible":1,"analysis":{"tags":"wearable drug delivery, electro-mechanical device","company":"Sorrel Medical","layoffs":null,"summary":"Sorrel Medical, a subsidiary of Eitan Group, is a company focused on the development and manufacture of wearable drug delivery solutions. In an interview, CEO Andrei Yosef discusses Sorrels differentiated electro-mechanical, connected wearable injection platform. The company recently opened a state-of-the-art manufacturing facility and signed a significant partnership with a large pharmaceutical company. Sorrels wearable drug delivery platform is designed to provide a patient-centric and partner-focused solution for self-administration of medications. The devices utilize an electro-mechanical pumping mechanism and have integrated connectivity capabilities. Sorrel is currently in various stages of development for different device configurations and expects to have multiple clinical studies completed by the end of next year. The companys partnering strategy involves collaborating with multiple pharmaceutical partners to customize devices for specific drug delivery requirements. Sorrels business structure benefits from the expertise and infrastructure of Eitan Group.","partners":["large pharmaceutical company"],"customers":null,"investors":null,"confidence":8,"key_topics":["wearable drug delivery","electro-mechanical device","partnership","manufacturing facility","pharmaceutical company"],"date_of_event":"July 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"jQk1MBYuMZuvQs3NHLbskvskqbxgWUSpaarCcBi1HXu0XoDxEsPW1W","news_summary":"ANDREI YOSEF, CEO, SORREL MEDICAL - ONdrugDelivery","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"69d34652-1818-4c8e-8eed-553c3eb1cd83","date":"Jul 22, 2020","link":"https://www.jpost.com/health-science/sorrel-medical-partners-with-tier-one-pharmaceutical-company-635903","source":"www.jpost.com","visible":1,"analysis":{"tags":"wearable drug delivery","company":"Sorrel Medical","layoffs":null,"summary":"Sorrel Medical has entered a strategic partnership with a tier-one pharmaceutical company to develop its wearable drug injection delivery device. The partnership aims to address the challenges of wearable drug delivery and provide a solution that does not interfere with a pharmaceutical companys processes. Sorrels device is prefilled and preloaded with medication, allowing pharma companies to maintain the drugs quality and sterility while reducing costs and time-to-market. The device is also designed to be primary container agnostic, giving drug developers the freedom to use their own choice of primary container. It enhances patient adherence to therapy by providing a reliable and easy-to-use system. The device is attached to the patients body via a sticker patch and includes smart sensors and indicators for successful self-administration.","partners":["tier-one pharmaceutical company"],"customers":null,"investors":null,"confidence":8,"key_topics":["Wearable drug delivery","Partnership","Pharmaceutical company","Patient adherence","Device features"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Sg2T5fpVidFH1wRa36XWc0JC1rbtqHvLBJvi4iltP30mHEJxj6Ki25","news_summary":"https://www.jpost.com/health-science/sorrel-medical-partners-with-tier-one-pharmaceutical-company-635903","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"cadf9639-aa82-44ad-ac72-d07d62b42245","date":"Jul 21, 2020","link":"https://www.prnewswire.com/il/news-releases/wearable-drug-delivery-provider-sorrel-medical-partners-with-leading-global-pharmaceutical-manufacturer-301096978.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"strategic partnership","company":"Sorrel Medical","layoffs":null,"summary":"Sorrel Medical has entered into a strategic partnership with a leading pharmaceutical company to develop and introduce next-generation wearable drug delivery solutions. The partnership will involve various molecule development initiatives across Sorrels wearable drug delivery platform. Sorrels on-body injectors are designed to enhance the patient experience and encourage adherence to treatment therapies. The devices are discreet, versatile, and attach to the patients body via a sticker patch. The partnership aims to provide safe, versatile, and easy-to-use devices for the changing nature of injectable drugs. Sorrel Medical is a medical device company focused on the development and manufacturing of wearable injectors for large volume and highly viscous therapies.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["wearable drug delivery","strategic partnership","patient adherence","pharmaceutical companies","platform-based injectors"],"date_of_event":"July 21, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"BP3nkoyAtbG2XieqhIxFSJ1PeBIfMij7QjCrMq4ReSOULmsDSu0udL","news_summary":"Wearable Drug Delivery Provider Sorrel Medical Partners with Leading Global Pharmaceutical Manufacturer","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"48cd7ce9-402c-4963-8625-27ce56107c5b","date":"Jul 7, 2020","link":"https://www.prnewswire.com/il/news-releases/sorrel-medical-opens-new-manufacturing-facility-increasing-clinical-and-commercial-supply-capabilities-of-wearable-drug-delivery-devices-301088997.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"wearable drug delivery devices","company":"Sorrel Medical","layoffs":null,"summary":"Sorrel Medical has announced the opening of a new manufacturing facility with cleanroom facilities to accommodate the production of wearable drug delivery devices. The facility will support the companys growth and enable it to meet the needs of global pharmaceutical partner programs. The cleanroom is designed to reduce contamination and control environmental parameters. Sorrels wearable drug delivery devices are designed to enhance the patient experience and encourage adherence to treatment therapies. The company aims to bring next-generation drug delivery solutions to patients with chronic and high burden conditions.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["manufacturing facility","scalability","clinical trials","commercial supply","patient experience"],"date_of_event":"July 7, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"OaX51ijCcQUeyaLWJNvidnUWKY8ZPcWPWC5pf0V2wAIazxTrRIAtKj","news_summary":"Sorrel Medical Opens New Manufacturing Facility, Increasing Clinical and Commercial Supply Capabilities of Wearable Drug Delivery Devices","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"e6bd0a4c-6dd8-4215-bbb9-e033bf34a201","date":"Feb 18, 2020","link":"https://www.prnewswire.com/il/news-releases/eitan-group-appoints-igal-shany-as-ceo-of-eitan-groups-q-core-medical-ltd-and-eitan-group-president-301006431.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"appointment, CEO, infusion therapy, expansion","company":"Eitan Group","layoffs":null,"summary":"Eitan Group has announced the appointment of Igal Shany as the CEO of Q Core Medical Ltd. and President of Eitan Group. Shany is a veteran of the tech world and has experience in business development and marketing. He will be responsible for driving further expansion of the company across the care continuum with its innovative infusion products. The appointment is seen as a positive move for the companys growth. Eitan Group is focused on infusion therapy and technologies, developing systems for hospital care and wearable solutions for self-administration. The company aims to improve patient outcomes and establish itself as a leader in the infusion industry.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["CEO appointment","infusion therapy","expansion","innovative products","customer focus"],"date_of_event":"February 18, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Management Changes","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"miaELJ17WmLtID6fe7LVsJBwvPuMuty1teyUgl753L4AxdkIPtO3PO","news_summary":"Eitan Group Appoints Igal Shany as CEO of Eitan Group's Q Core Medical Ltd., and Eitan Group President","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"0d7ebd9a-8bcb-4fd4-b58d-2f723d8d8706","date":"Feb 4, 2020","link":"https://www.prnewswire.com/news-releases/sorrel-medical-appoints-bentsi-algazi-vice-president-of-operations-as-company-gears-up-for-clinical-and-commercial-manufacturing-300998427.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"appointment, wearable drug delivery devices","company":"Sorrel Medical","layoffs":null,"summary":"Sorrel Medical has appointed Bentsi Algazi as Vice President of Operations to meet growing interest in its wearable self-injection devices. Algazi will oversee the companys supply chain, engineering, production, and vendor management activities. The appointment comes as Sorrels wearable drug delivery platform gains attention from leading pharmaceutical and biotech companies. Algazi brings over 20 years of managerial experience in R&D, operations, procurement, and production management. Sorrel is focused on the development and manufacturing of pre-filled wearable injectors for the self-administration of medications.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["appointment","wearable drug delivery devices","operations","supply chain management","pharmaceutical partners"],"date_of_event":"2020-02-04","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"bDmUHZYp2oOaCqFCi58xzFss2MWkp7qEtCGvhCccS3JN1uFZVWnxlH","news_summary":"Sorrel Medical Appoints Bentsi Algazi Vice President of Operations, as Company Gears Up for Clinical and Commercial Manufacturing","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"0376962d-09bc-4cec-aca7-53b43f93a443","date":"Nov 28, 2019","link":"https://www.jpost.com/opinion/hillels-tech-corner-hospital-treatment-at-home-609341","source":"www.jpost.com","visible":1,"analysis":{"tags":"medical self-administration","company":"Sorrel Medical","layoffs":null,"summary":"Sorrel Medical, a company specializing in medical self-administration, aims to overcome the challenges of patient adherence and alternative drug delivery systems. They have developed a prefilled and preloaded device that allows pharmaceutical companies to maintain drug quality and sterility while reducing costs and time-to-market. The device is easily attached to the patients body and provides reliable and easy-to-use self-administration. Sorrels solution addresses the need for comfortable and independent medical treatment at home, reducing the need for hospital visits. The article expresses optimism about Sorrels mission and its potential to revolutionize healthcare.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["medical self-administration","wearable drug delivery devices","prefilled and preloaded device","patient adherence","home medical treatment"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"6Ut7N5JciDIw8wbjF7xnp5DYfdAYbgmmLsv1jnu7tNn358v56jwJ3a","news_summary":"https://www.jpost.com/opinion/hillels-tech-corner-hospital-treatment-at-home-609341","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"e275efd4-50b1-49e2-9e22-2f3faa337ceb","date":"Nov 12, 2019","link":"https://www.drugdeliverybusiness.com/eitan-group-launches-preventative-maintenance-servicing-tool-for-sapphire-infusion-pumps/","source":"www.drugdeliverybusiness.com","visible":1,"analysis":{"tags":"preventative maintenance","company":"Eitan Group","layoffs":null,"summary":"The Eitan Group has launched a new preventative maintenance servicing tool called FasTestPM for its Sapphire infusion pumps. The tool allows users to perform full maintenance tests on the pumps, reducing costs and runtime. It will cost 90% less than the previous maintenance kit and has a total runtime of four minutes. The company aims to revolutionize the concept of preventative maintenance by providing automatic, paperless tests that can be performed anywhere. The tool will officially launch in December at the ASHP Midyear Clinical Meeting and Exhibition in Las Vegas. The Eitan Group had previously signed a deal with InfuSystem for repair services on its Sapphire infusion pumps.","partners":["InfuSystem"],"customers":null,"investors":null,"confidence":8,"key_topics":["preventative maintenance","Sapphire infusion pumps","FasTestPM","maintenance costs","runtime"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"SHEOf4cyghP6LYaUa9FA0DhipwNHi4VamR99MRD8JdoRn7V2plPLQ0","news_summary":"Eitan Group launches preventative maintenance servicing tool for Sapphire infusion pumps - Drug Delivery Business","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"02f44b68-29fd-4d6b-af21-103afee441fc","date":"Jul 12, 2019","link":"https://www.massdevice.com/avoset-to-develop-infusion-pump-with-unnamed-pharma-giant/","source":"www.massdevice.com","visible":1,"analysis":{"tags":"connected infusion pump","company":"Avoset Health","layoffs":null,"summary":"Avoset Health plans to develop a connected infusion pump with an unnamed pharmaceutical company. The product is set to debut in early 2021. The technology allows physicians and pharmacists to track patient infusions and intervention needs.","partners":"unnamed pharmaceutical company","customers":null,"investors":null,"confidence":9,"key_topics":["infusion pump","pharmaceutical company","technology","physicians","pharmacists"],"date_of_event":"July 12, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"CxqjeTMQ2aNE94MM7VBBtN26EngNRpMaXB2sUpvPOV9PjeP1urAeJs","news_summary":"Avoset to develop infusion pump with unnamed pharma giant","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"8d4b1266-bf32-46d4-a86b-bdcdc4e27c17","date":"Jul 9, 2019","link":"https://www.prnewswire.com/il/news-releases/avoset-health-to-develop-connected-dedicated-infusion-pump-with-tier-one-global-pharma-partner-300881429.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"connected infusion solutions","company":"Avoset Health","layoffs":null,"summary":"Avoset Health, a provider of connected infusion solutions for home care, has been selected by a leading manufacturer of medical devices and pharmaceutical products to develop a connected dedicated infusion pump. The pump is expected to be released in early 2021. Avosets technology allows its pumps to track patients treatment adherence through a cloud-connected system, providing data to healthcare providers for improved patient outcomes. Avoset is part of the Eitan Group, which is focused on developing connected infusion solutions across the care continuum.","partners":"Eitan Group","customers":null,"investors":null,"confidence":9,"key_topics":["connected infusion pump","treatment adherence","patient outcomes","home infusion","platform solution"],"date_of_event":"July 9, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"I0K5QbjF2ejGLwA31BlHuv637yWigF1SkiQujwE16Oee2ZaiPoqBEH","news_summary":"Avoset Health to Develop Connected Dedicated Infusion Pump With Tier-one Global Pharma Partner","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"a95b71ff-4841-4f42-aa1e-fd9b7773fa6f","date":"Jun 5, 2019","link":"https://www.prnewswire.com/il/news-releases/sorrel-medicals-wearable-drug-delivery-platform-wins-2019-medtech-breakthrough-award-300862323.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"technology, drug delivery","company":"Sorrel Medical","layoffs":null,"summary":"Sorrel Medical has been awarded the Best New Technology Solution in Drug Delivery designation from MedTech Breakthrough for its wearable drug delivery platform. The platform is designed to provide patients with a simple and efficient means of drug administration, particularly for large volume and high viscosity medications. Sorrels devices are discreet, fully-disposable, and able to meet a variety of specific drug requirements from multiple pharmaceutical partners. The devices utilize smart sensors and UV LED technology for successful self-administration and disinfection. They can also connect to Bluetooth and NFC platforms for sharing treatment information. The award recognizes Sorrels patient-centric approach to medical solutions.","partners":"MedTech Breakthrough","customers":null,"investors":null,"confidence":9,"key_topics":["wearable drug delivery devices","Best New Technology Solution","drug administration","pre-filled drug delivery devices","MedTech Breakthrough Awards"],"date_of_event":"June 5, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Afrbq3oJzRYc3vLGDurBMwmrBiJinE104TdYJvefXqX7DNHHsgHpIG","news_summary":"Sorrel Medical's Wearable Drug Delivery Platform Wins 2019 MedTech Breakthrough Award","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7c5fb7cd-49ec-44f8-bc53-e4af168ca8f2","date":"Mar 27, 2019","link":"https://en.globes.co.il/en/article-from-flash-memory-to-drug-delivery-1001279597","source":"en.globes.co.il","visible":1,"analysis":{"tags":"Management Changes, Acquisition, Layoffs","company":"Saifun","layoffs":"30","summary":"Boaz Eitan, founder and CEO of technology company Saifun, left the company after a turbulent period that saw the company lose its main customer and its share price plummet. Saifun, which developed unique non-volatile memory technology, attempted to recover by merging with US company Spansion. However, Spansion was also hit hard in the financial crisis of 2008-2009 and went bankrupt. Eitan left the company and his shares were worth nothing. He then worked on building QCore Medical, a company developing infusion pumps.","partners":"Spansion","customers":"N/A","investors":"N/A","confidence":"8","key_topics":["CEO Departure","Merger","Bankruptcy","Layoffs","New Venture"],"date_of_event":"March 27, 2019","valuation_amount":"N/A","impact_on_company":"growth-negative","investment_amount":"N/A","structured_issues":["Management Changes","Acquisition","Layoffs"],"acquisition_amount":"N/A","structuredIssuesShow":"#Management Changes  #Acquisition  #Layoffs","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"3wiPhqzeMhbKKQK8chZQJfPKlbdlcKdyL5178vAsP3D1OY1fEtKLaM","news_summary":"From flash memory to drug delivery","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"a6102d8d-db81-4036-8ce5-a44555d2d3a3","date":"Mar 11, 2019","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3758023,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"expansion","company":"Q-Core Medical Ltd.","layoffs":null,"summary":"Q-Core Medical Ltd. is opening a new European regional headquarters in Marseille, France. The company develops infusion pumps for hospital and ambulatory care. The pumps can be used for various IV therapies. Q-Core Medical was established in 2009 and employs 170 people.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Q-Core Medical","infusion pumps","European regional headquarters","Marseille","IV therapies"],"date_of_event":"11.03.19","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ap9nX5rvRFHvuRqajplDOK4NxPscXoz3qOVUaxvHuvDvSVtolTbR0B","news_summary":"Q-Core Medical to Open European Regional Headquarters in Marseille","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"1a5a1e5a-22bd-45e8-b9db-a602a999076d","date":"Jan 8, 2015","link":"https://www.prnewswire.com/news-releases/hospira-announces-significant-progess-on-global-device-strategy-300017812.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"device strategy","company":"Hospira, Inc.","layoffs":null,"summary":"Hospira, Inc. has announced significant progress on its global device strategy, including the lifting of an import alert by the FDA on its infusion devices. This allows the company to sell these devices to new and existing customers without medical necessity certificates. Hospira also plans to launch new next-generation pump technology in 2015, as well as develop a next-generation platform of pumps in collaboration with partner Q Core Medical. The companys device strategy is aimed at addressing customer needs, supporting quality improvement efforts, and positioning the company for future growth. Hospira is a global leader in injectable drugs and infusion technologies.","partners":["Q Core Medical"],"customers":null,"investors":null,"confidence":8,"key_topics":["device strategy","product launches","future technology","partnership","biosimilars"],"date_of_event":"January 5, 2015","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"nktxVel6hYBg8A93nbrtyH7EBRtoZ9oW7NQIq9yLclWFhtuCkOT5Se","news_summary":"Hospira Announces Significant Progess On Global Device Strategy","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":21,"events":null,"techcommunityinvolvement":null,"mediagallery":[{"id":"L6K2DvaUIxnsjJgyRB6AvuqC2HWXPt81tjV2qFuESfjePIKflIVrZQ","timestamp":"2025-09-10 14:43:21.000000","resources_type":1,"resources_title":"Sapphire Multi-Therapy Infusion Pump","resources_file_name":"$RRvIrx0iW0CcCuuNCUTfDVhzH7thvokHqrEANatKsHf8agPWWRGzBL.png","alt":"Sapphire Multi-Therapy Infusion Pump logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$RRvIrx0iW0CcCuuNCUTfDVhzH7thvokHqrEANatKsHf8agPWWRGzBL.png","url":"https://storage.googleapis.com/clean-finder-353810/$RRvIrx0iW0CcCuuNCUTfDVhzH7thvokHqrEANatKsHf8agPWWRGzBL.png"},{"id":"8tfRjh96parxydqJXgw8yKFBC3xKJxzGnQbZsjygutsR1WxsMua1zc","timestamp":"2025-09-10 14:43:20.000000","resources_type":1,"resources_title":"Eitan Insights Digital Health Platform","resources_file_name":"$YtuntEKft8DHDsA3TStnYFISBs78ubz69WTZ1DSMXIorPG7Kodps7G.png","alt":"Eitan Insights Digital Health Platform logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$YtuntEKft8DHDsA3TStnYFISBs78ubz69WTZ1DSMXIorPG7Kodps7G.png","url":"https://storage.googleapis.com/clean-finder-353810/$YtuntEKft8DHDsA3TStnYFISBs78ubz69WTZ1DSMXIorPG7Kodps7G.png"},{"id":"RjieoeMVwJTaxO04pCFvvaHLURoffQgP1nDGmAwscrIvJStwWLIr1S","timestamp":"2025-09-10 14:43:19.000000","resources_type":1,"resources_title":"Infusion Pumps","resources_file_name":"$BYNdxZjWWaoeZOyfw1uDQhuvwEHhRCXAUbpFoSJXMED28k8nDzMPdk.png","alt":"Infusion Pumps logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$BYNdxZjWWaoeZOyfw1uDQhuvwEHhRCXAUbpFoSJXMED28k8nDzMPdk.png","url":"https://storage.googleapis.com/clean-finder-353810/$BYNdxZjWWaoeZOyfw1uDQhuvwEHhRCXAUbpFoSJXMED28k8nDzMPdk.png"}],"tags":["drug-delivery","home-care","patient-engagement","medical-devices","non-invasive","digital-healthcare","wearable","operating-rooms","hospitals","seniors","remote-monitoring","sensors","pharma-companies","veterinary","medical-technologies","patients","pumps","digital-therapeutics","healthcare-providers","treatments","personalization"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nqIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvavo4KDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["Sapphire","Avoset","Eitan Insights"],"geomarkets":["Europe","North America","Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":0,"lastfunding":"Undisclosed","totalrounds":0,"fundingstage":"Mature","totalfunding":"Undisclosed","publicinvestors":0,"lastpublicfunding":null,"totalpublicrounds":0,"totalpublicfunding":0},"team":[{"name":"Dr. Boaz Eitan","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4JvnuZkJDA","bounced":false,"claimed":0,"founder":1,"urlname":"dr-boaz-eitan","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg64jj_wsM","position":"Chairman, CTO","last_name":"Eitan","claimtoken":"OXhbLenMHfxlO0Ta6TZKHd04qAWmqyKhmxPBNxrgqvzuApheJUNxUG","first_name":"Dr. Boaz","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/boaz-eitan-551183118/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-10-27 17:23:58.000000","initials":"DE","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Tally Eitan","email":"","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4OuI9-EIDA","bounced":false,"claimed":0,"founder":0,"urlname":"tally-eitan","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgq-n9lQkM","position":"Board Member","last_name":"Eitan","claimtoken":"79534e6e43a9a7245a5baa38d78c5c3a466d681152674d89a59b6dc1744f63c6","first_name":"Tally","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/tally-eitan-63024453/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2021-02-23 10:22:40.000000","initials":"TE","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Shaul Eitan","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4Ku06vULDA","bounced":false,"claimed":0,"founder":1,"urlname":"shaul-eitan-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg25uUwgkM","position":"CEO","last_name":"Eitan","claimtoken":"nCrHEYHVvtQxjynutPt9s8fWCttQBeWI8Ykw9zHCJnRgmix6TE5eaF","first_name":"Shaul","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/shaul-eitan-4437573/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-10-27 17:12:25.000000","initials":"SE","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Roger Massengale","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4NvG2KMJDA","bounced":false,"claimed":0,"founder":0,"urlname":"roger-massengale","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgq-mSxwsM","position":"Chief Commercial Officer, Medication Delivery Solutions","last_name":"Massengale","claimtoken":"F5EoCcPuFnGw26fVqbJTOwwG833lCCtesRXStBBnHI5z0wWZ5JVqc7","first_name":"Roger","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/roger-massengale-3a88791/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-10-27 17:13:18.000000","initials":"RM","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Guy Hadar","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4JuXhooKDA","bounced":false,"claimed":0,"founder":0,"urlname":"guy-hadar","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg29nPqAgM","position":"EVP, General Counsel","last_name":"Hadar","claimtoken":"KFHFH2cB7XLujRuz0VNF4YUn1LkfNOqeaQfTLq6iAVTBdOwhLZWrVh","first_name":"Guy","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/guy-hadar-2229561a/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-10-27 17:12:37.000000","initials":"GH","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Mindy Katz","email":"","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPnEofsKDA","bounced":false,"claimed":1,"founder":0,"urlname":"mindy-katz-2","visible":1,"memberid":"zFiJXcDUydmM9WDGmsBveI08tMRBWm4eVt4oon5P1ZkUFjDyZRGLIg","position":"Marketing Director","last_name":"Katz","claimtoken":"BSYv3HEbVz1dQvOrYWVjLMK8TR7Ja157rpX5RIRUotMn9ef4xoKY0x","first_name":"Mindy","picturekey":null,"claimeddate":"2025-01-13","linkedinurl":"https://www.linkedin.com/in/mindy-katz-53729025/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2025-01-13 17:57:36.000000","initials":"MK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Mindy Katz","email":"mindyatara@gmail.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPnEofsKDA","bounced":false,"claimed":1,"founder":null,"urlname":"mindy-katz-2","visible":1,"memberid":"dTr80HzKbF3CxhMxxgDHMRuMCOsUGf4ZppkE3RanzsxKhzihqwCgO6","position":"","last_name":"Katz","claimtoken":null,"first_name":"Mindy","picturekey":"$6VLgRXYYciAooKU0PYPRCi31yJeisotiN0Yym9hDTJeluAmO5mNFqg","claimeddate":"2025-09-10","linkedinurl":"https://www.linkedin.com/in/mindy-katz-53729025/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$6VLgRXYYciAooKU0PYPRCi31yJeisotiN0Yym9hDTJeluAmO5mNFqg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Mindy Katz","email":"mindyatara@gmail.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPnEofsKDA","bounced":false,"claimed":1,"founder":null,"urlname":"mindy-katz-2","visible":1,"memberid":"td5ETXORhczEEPrfutPFOeBwBwt6wzItCob8WZBDy0lSjbwESnqYa0","position":"","last_name":"Katz","claimtoken":null,"first_name":"Mindy","picturekey":"$6VLgRXYYciAooKU0PYPRCi31yJeisotiN0Yym9hDTJeluAmO5mNFqg","claimeddate":"2025-09-10","linkedinurl":"https://www.linkedin.com/in/mindy-katz-53729025/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$6VLgRXYYciAooKU0PYPRCi31yJeisotiN0Yym9hDTJeluAmO5mNFqg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNqyo8cLDA","fullname":"Yotam Maman"},"biverifydate":"2021-02-23T00:00:00.000Z","crunchbaseid":"","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Eden Zurek","creator_email":"eden.zurek@finnpartners.com","createdate":"2021-02-22T00:00:00.000Z","biverification":"Yotam Maman","sectorverification":null,"affiliatedOrganizations":null,"timeline":[],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"1/2009","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Eitan Medical","logourl":"https://storage.googleapis.com/clean-finder-353810/$dgJKPK72JhbtYpexpt91BxaV1cYn0HmREQFRtQC06xD341k8BFD6lr.png","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$dgJKPK72JhbtYpexpt91BxaV1cYn0HmREQFRtQC06xD341k8BFD6lr.png","seoabout":"Eitan Medical is a medical device company that develops infusion therapy technologies for hospital care and ambulatory settings. Eitan Medical provides con...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":8,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drug Delivery","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Patient Remote Monitoring","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Recreational & Lifestyle","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nqIKDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pet Owners","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvavo4KDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Seniors","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Recreational & Lifestyle#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nqIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drug Delivery#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Patient Remote Monitoring#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA>Seniors#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Recreational & Lifestyle#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nqIKDA>Pet Owners#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvavo4KDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drug Delivery#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Patient Remote Monitoring#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA|2:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA/Recreational & Lifestyle#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nqIKDA|3:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Recreational & Lifestyle#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nqIKDA/Pet Owners#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvavo4KDA|2:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA/Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA|3:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA/Seniors#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drug Delivery","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drug Delivery"}]},{"title":"Medical Devices","key":"0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-1-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]},{"title":"Digital Healthcare","key":"0-0-2","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare","children":[{"title":"Patient Remote Monitoring","key":"0-0-2-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Patient Remote Monitoring"}]}]}],"targetCustomer":[{"title":"Consumers","key":"0-0","path":"IndustryClassificationModel>Consumers","children":[{"title":"Recreational & Lifestyle","key":"0-0-0","path":"IndustryClassificationModel>Consumers>Recreational & Lifestyle","children":[{"title":"Pet Owners","key":"0-0-0-0","path":"IndustryClassificationModel>Consumers>Recreational & Lifestyle>Pet Owners"}]},{"title":"Demographics & Family","key":"0-0-1","path":"IndustryClassificationModel>Consumers>Demographics & Family","children":[{"title":"Seniors","key":"0-0-1-0","path":"IndustryClassificationModel>Consumers>Demographics & Family>Seniors"}]}]},{"title":"Healthcare & Life Sciences","key":"0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Patients","key":"0-1-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"},{"title":"Providers","key":"0-1-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]},{"title":"Life Sciences","key":"0-1-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-1-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]}]}],"coreTechnology":[{"title":"Sensing","key":"0-0","path":"TechnologyClassificationModel>Sensing"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drug Delivery","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Patient Remote Monitoring","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Recreational & Lifestyle","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nqIKDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pet Owners","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvavo4KDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Seniors","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drug Delivery","Medical Devices","Medical Treatment & Therapeutics","Digital Healthcare","Patient Remote Monitoring"],"coreTechnology":["Sensing"],"targetCustomer":["Consumers","Recreational & Lifestyle","Pet Owners","Demographics & Family","Seniors","Healthcare & Life Sciences","Healthcare","Patients","Providers","Life Sciences","Pharmaceuticals"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}